Patents by Inventor Jeffrey E. Cortopassi

Jeffrey E. Cortopassi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transdermal dosage form for low-melting point active agent
    Patent number: 9452145
    Abstract: A drug-containing patch allows transdermal administration of a drug. The patch features a hydrophobic reservoir containing the drug, where the reservoir has a first surface and a second surface. A drug-impermeable backing overlies the first surface of the reservoir. A release sheet may overlie the second surface of the reservoir. The hydrophobic reservoir contains a drug and a hydrophobic matrix, where the hydrophobic matrix includes a hydrophobic filler in an amount which is effective to adsorb said drug; and a mixture of polyisobutylene and mineral oil. The hydrophobic matrix may contain hydrophobic colloidal silica as the hydrophobic filler. The hydrophobic reservoir layer may serve as a skin-contacting adhesive layer. Alternatively, a release-controlling adhesive layer may serve as the skin-contacting adhesive layer. The release-controlling adhesive layer may contain hydrophobic colloidal silica and a mixture of polyisobutylene and mineral oil.
    Type: Grant
    Filed: May 29, 2015
    Date of Patent: September 27, 2016
    Assignee: Mylan Inc
    Inventors: Arunprasad Sivaraman, Tyler D. Simmons, Gregory T. Fieldson, Adam C. Sorensen, Jeffrey E. Cortopassi
  • TRANSDERMAL DOSAGE FORM FOR LOW-MELTING POINT ACTIVE AGENT
    Publication number: 20150258037
    Abstract: A drug-containing patch allows transdermal administration of a drug. The patch features a hydrophobic reservoir containing the drug, where the reservoir has a first surface and a second surface. A drug-impermeable backing overlies the first surface of the reservoir. A release sheet may overlie the second surface of the reservoir. The hydrophobic reservoir contains a drug and a hydrophobic matrix, where the hydrophobic matrix includes a hydrophobic filler in an amount which is effective to adsorb said drug; and a mixture of polyisobutylene and mineral oil. The hydrophobic matrix may contain hydrophobic colloidal silica as the hydrophobic filler. The hydrophobic reservoir layer may serve as a skin-contacting adhesive layer. Alternatively, a release-controlling adhesive layer may serve as the skin-contacting adhesive layer. The release-controlling adhesive layer may contain hydrophobic colloidal silica and a mixture of polyisobutylene and mineral oil.
    Type: Application
    Filed: May 29, 2015
    Publication date: September 17, 2015
    Inventors: Arunprasad SIVARAMAN, Tyler D. SIMMONS, Gregory T. FIELDSON, Adam C. SORENSEN, Jeffrey E. CORTOPASSI
  • Transdermal dosage form for low-melting point active agent
    Patent number: 9072682
    Abstract: A drug-containing patch allows transdermal administration of a drug. The patch features a hydrophobic reservoir containing the drug, where the reservoir has a first surface and a second surface. A drug-impermeable backing overlies the first surface of the reservoir. A release sheet may overlie the second surface of the reservoir. The hydrophobic reservoir contains a drug and a hydrophobic matrix, where the hydrophobic matrix includes a hydrophobic filler in an amount which is effective to adsorb said drug; and a mixture of polyisobutylene and mineral oil. The hydrophobic matrix may contain hydrophobic colloidal silica as the hydrophobic filler. The hydrophobic reservoir layer may serve as a skin-contacting adhesive layer. Alternatively, a release-controlling adhesive layer may serve as the skin-contacting adhesive layer. The release-controlling adhesive layer may contain hydrophobic colloidal silica and a mixture of polyisobutylene and mineral oil.
    Type: Grant
    Filed: December 31, 2012
    Date of Patent: July 7, 2015
    Assignee: Mylan Inc.
    Inventors: Arunprasad Sivaraman, Tyler D. Simmons, Gregory T. Fieldson, Adam C. Sorensen, Jeffrey E. Cortopassi
  • TRANSDERMAL DOSAGE FORM FOR LOW-MELTING POINT ACTIVE AGENT
    Publication number: 20140188057
    Abstract: A drug-containing patch allows transdermal administration of a drug. The patch features a hydrophobic reservoir containing the drug, where the reservoir has a first surface and a second surface. A drug-impermeable backing overlies the first surface of the reservoir. A release sheet may overlie the second surface of the reservoir. The hydrophobic reservoir contains a drug and a hydrophobic matrix, where the hydrophobic matrix includes a hydrophobic filler in an amount which is effective to adsorb said drug; and a mixture of polyisobutylene and mineral oil. The hydrophobic matrix may contain hydrophobic colloidal silica as the hydrophobic filler. The hydrophobic reservoir layer may serve as a skin-contacting adhesive layer. Alternatively, a release-controlling adhesive layer may serve as the skin-contacting adhesive layer. The release-controlling adhesive layer may contain hydrophobic colloidal silica and a mixture of polyisobutylene and mineral oil.
    Type: Application
    Filed: December 31, 2012
    Publication date: July 3, 2014
    Applicant: MYLAN, INC.
    Inventors: Arunprasad Sivaraman, Tyler D. Simmons, Gregory T. Fieldson, Adam C. Sorenson, Jeffrey E. Cortopassi